X Rabasseda

1.0k total citations
81 papers, 818 citations indexed

About

X Rabasseda is a scholar working on Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, X Rabasseda has authored 81 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Epidemiology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in X Rabasseda's work include Hematological disorders and diagnostics (4 papers), HIV/AIDS drug development and treatment (4 papers) and Migraine and Headache Studies (4 papers). X Rabasseda is often cited by papers focused on Hematological disorders and diagnostics (4 papers), HIV/AIDS drug development and treatment (4 papers) and Migraine and Headache Studies (4 papers). X Rabasseda collaborates with scholars based in United States, Spain and France. X Rabasseda's co-authors include M. Bayés, J. Prous, J. Castañer, J. Silvestre, J. Castañer, Paul Norman, Jean‐Sébastien Silvestre, Bin Ren, Naseruddin Höti and Yanan Wang and has published in prestigious journals such as Drugs of today, Methods and Findings in Experimental and Clinical Pharmacology and Drugs of the Future.

In The Last Decade

X Rabasseda

76 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
X Rabasseda United States 14 252 152 150 129 73 81 818
Frits Moolenaar Netherlands 21 425 1.7× 129 0.8× 74 0.5× 121 0.9× 194 2.7× 68 1.3k
Stephen A. Bai United States 19 157 0.6× 56 0.4× 78 0.5× 145 1.1× 126 1.7× 34 847
Dong Chan Kim South Korea 14 204 0.8× 107 0.7× 165 1.1× 70 0.5× 54 0.7× 80 853
Tomohiro Yamamoto Japan 15 180 0.7× 105 0.7× 199 1.3× 38 0.3× 40 0.5× 44 724
Russell Gotschall United States 21 533 2.1× 84 0.6× 154 1.0× 112 0.9× 178 2.4× 37 1.7k
Check Y. Quon United States 15 186 0.7× 79 0.5× 46 0.3× 61 0.5× 94 1.3× 38 818
Clarence L. Young United States 14 153 0.6× 99 0.7× 50 0.3× 173 1.3× 32 0.4× 33 889
Ganesh S. Moorthy United States 18 290 1.2× 48 0.3× 84 0.6× 153 1.2× 124 1.7× 50 873
Pankaj Wadhwa India 19 347 1.4× 358 2.4× 166 1.1× 99 0.8× 89 1.2× 98 1.3k
Bertrand Diquet France 18 264 1.0× 58 0.4× 38 0.3× 94 0.7× 126 1.7× 52 1.0k

Countries citing papers authored by X Rabasseda

Since Specialization
Citations

This map shows the geographic impact of X Rabasseda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by X Rabasseda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites X Rabasseda more than expected).

Fields of papers citing papers by X Rabasseda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by X Rabasseda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by X Rabasseda. The network helps show where X Rabasseda may publish in the future.

Co-authorship network of co-authors of X Rabasseda

This figure shows the co-authorship network connecting the top 25 collaborators of X Rabasseda. A scholar is included among the top collaborators of X Rabasseda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with X Rabasseda. X Rabasseda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rabasseda, X. (2014). A report from the 167th American Psychiatric Association Annual Meeting. 50(7). 527–542.
3.
Rabasseda, X, et al.. (2014). Developments in clinical trials: a Pharma Matters report. Drugs of today. 50(8). 567–567. 1 indexed citations
4.
Rabasseda, X. (2014). A report from the 167th American Psychiatric Association AnnualMeeting (May 3-7 - New York, U.S.A.). Drugs of today. 50(7). 527–527. 2 indexed citations
5.
6.
Rabasseda, X. (2011). Meeting report: A report from the 164th American Psychiatric Association (May 14-18, 2011 - Honolulu, Hawai'i, U.S.A.). 47(8). 625–644. 3 indexed citations
7.
Rabasseda, X, et al.. (2010). A report from the 46th Annual Meeting of the American Society ofClinical Oncology (June 4-8, 1020 - Chicago, Illinois, USA). Drugs of today. 46(9). 699–699. 1 indexed citations
8.
9.
10.
Rabasseda, X, et al.. (2005). Enhanced hypercholesterolemia therapy: The ezetimibe/simvastatincombination. Drugs of today. 41(5). 317–317. 3 indexed citations
11.
Rabasseda, X. (2004). Dutasteride: A potent dual inhibitor of 5-alpha-reductase forbenign prostatic hyperplasia. Drugs of today. 40(8). 649–649. 3 indexed citations
12.
Rabasseda, X, et al.. (2004). The soluble tumor necrosis factor receptor etanercept: A newstrategy for the treatment of autoimmune rheumatic disease. Drugs of today. 40(4). 281–281. 19 indexed citations
13.
Rabasseda, X, et al.. (2004). Tegaserod: A serotonin 5-HT4 receptor agonist for treatment ofconstipation-predominant irritable bowel syndrome. Drugs of today. 40(12). 1013–1013. 7 indexed citations
14.
Rabasseda, X. (2002). Ramosetron, a 5-HT3 receptor antagonist for the control of nauseaand vomiting. Drugs of today. 38(2). 75–75. 85 indexed citations
15.
Rabasseda, X, et al.. (2001). Esomeprazole: A significant advance beyond omeprazole in thetreatment of acid-related disease. Drugs of today. 37(11). 767–767. 2 indexed citations
16.
Rabasseda, X. (2001). Tenecteplase (TNK tissue plasminogen activator): A new fibrinolyticfor the acute treatment of myocardial infarction. Drugs of today. 37(11). 749–749. 1 indexed citations
17.
Rabasseda, X. (2001). Almotriptan in the treatment of migraine. Drugs of today. 37(6). 359–359. 2 indexed citations
18.
Rabasseda, X, et al.. (2001). Amoxicillin-sulbactam: A clinical and therapeutic review. Drugs of today. 37(3). 193–193. 12 indexed citations
19.
Rabasseda, X. (2001). Almotriptan in the treatment of migraine. Drugs of today. 37(1). 5–5. 4 indexed citations
20.
Nappi, Giuseppe, et al.. (1994). Pramiracetam: A nootropic agent with improved efficacy in patients with senile or presenile cognitive impairment. Drugs of today. 30(6). 469–482. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frits Moolenaar Breakdown of academic impact, for papers by Stephen A. Bai Breakdown of academic impact, for papers by Dong Chan Kim Breakdown of academic impact, for papers by Tomohiro Yamamoto Breakdown of academic impact, for papers by Russell Gotschall Breakdown of academic impact, for papers by Check Y. Quon Breakdown of academic impact, for papers by Clarence L. Young Breakdown of academic impact, for papers by Ganesh S. Moorthy Breakdown of academic impact, for papers by Pankaj Wadhwa Breakdown of academic impact, for papers by Bertrand Diquet
Rankless by CCL
2026